Comparative Performance of ATRIA, CHADS2, and CHA2DS2-VASc Risk Scores Predicting Stroke in Patients With Atrial Fibrillation: Results From a National Primary Care Database

Journal of the American College of Cardiology

Volumn 66, Issue 17, 2015, Pages 1851-1859

  Van Den Ham, Hendrika A ^a   Klungel, Olaf H ^a   Singer, Daniel E ^b   Leufkens, Hubert G M ^a   Van Staa, Tjeerd P ^a,c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

anticoagulants; atrial fibrillation; risk prediction; stroke; treatment decision

Indexed keywords

ANTITHROMBOCYTIC AGENT; WARFARIN; ANTICOAGULANT AGENT;

AGE DISTRIBUTION; AGED; ANTICOAGULATION AND RISK FACTORS IN ATRIAL FIBRILLATION RISK SCORE; ARTICLE; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHA2DS2 VASC SCORE; CHADS2 SCORE; CLINICAL PRACTICE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SENSITIVITY ANALYSIS; TRANSIENT ISCHEMIC ATTACK; UNITED KINGDOM; VERY ELDERLY; CASE REPORT; COMORBIDITY; COMPLICATION; MIDDLE AGED; STROKE;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; COMORBIDITY; HUMANS; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; STROKE;

EID: 84945978079     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.08.033     Document Type: Article

References (30)

1. B.F. Gage, A.D. Waterman, W. Shannon, and et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870
2. G.Y.H. Lip, R. Nieuwlaat, R. Pisters, and et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation Chest 137 2010 263 272
3. A.J. Camm, G.Y. Lip, R. De Caterina, and et al. 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association Europace 14 2012 1385 1413
4. C.T. January, L.S. Wann, J.S. Alpert, and et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 64 2014 e1 e76
5. M.C. Fang, A.S. Go, Y. Chang, and et al. Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation J Am Coll Cardiol 51 2008 810 815
6. L. Friberg, M. Rosenqvist, and G.Y.H. Lip Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation Cohort Study Eur Heart J 33 2012 1500 1510
7. Stroke Risk in Atrial Fibrillation Working Group Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation Stroke 39 2008 1901 1910
8. J.B. Olesen, G.Y.H. Lip, M.L. Hansen, and et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study BMJ 342 2011 dl24
9. D. Poli, E. Antonucci, E. Grifoni, and et al. Stroke risk in atrial fibrillation patients on warfarin. Predictive ability of risk stratification schemes for primary and secondary prevention Thromb Haemost 101 2009 367 372
10. S. Rietbrock, E. Heeley, J. Plumb, and T. van Staa Chronic atrial fibrillation: incidence, prevalence, and prediction of stroke using the congestive heart failure, hypertension, age > 75, diabetes mellitus, and prior stroke or transient ischemic attack (CHADS2) risk stratification scheme Am Heart J 156 2008 57 64
11. T.P. Van Staa, E. Setakis, G. Di Tanna, and et al. A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice J Thromb Haemost 9 2011 39 48
12. D.E. Singer, Y. Chang, L.H. Borowsky, and et al. A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score J Am Heart Assoc 2 2013 e000250
13. A.S. Levey, J.P. Bosch, J.B. Lewis, and et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 130 1999 461 470
14. E.W. Steyerberg Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating 2008 Springer Science & Business Media Dordrecht, the Netherlands
15. W.K. Kremers Concordance for Survival Time Data: Fixed and Time-Dependent Covariates and Possible Ties in Predictor and Time. Technical Report Series No. 80 2007 The Mayo Foundation Rochester, MN
16. M.J. Pencina, R.B. D'Agostino, and E.W. Steyerberg Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers Stat Med 30 2011 11 21
17. M.H. Eckman, D.E. Singer, J. Rosand, and S.M. Greenberg Moving the tipping point Circ Cardiovasc Qual Outcomes 4 2011 14 21
18. L. Friberg, M. Skeppholm, and A. Terént Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1 J Am Coll Cardiol 65 2015 225 232
19. N.R. Cook Assessing the incremental role of novel and emerging risk factors Curr Cardiovasc Risk Rep 4 2010 112 119
20. A. Gómez Outes, A. Terleira Fernández, G. Calvo-Rojas, and et al. Dabigatran, rivaroxaban, or apixaban versus warfarin in patients with nonvalvular atrial fibrillation: a systematic review and meta-analysis of subgroups Thrombosis 2013 2013 640723
21. G.Y.H. Lip, P. Nielsen, F. Skjøth, and et al. The value of the European Society of Cardiology guidelines for refining stroke risk stratification in patients with atrial fibrillation categorised as low risk using the anticoagulation and risk factors in atrial fibrillation stroke score: a nationwide cohort study Chest 146 2014 1337 1346
22. T. Chao, C. Liu, K. Wang, and et al. Using the CHA2DS2-VASc score for refining stroke risk stratification in 'low-risk'Asian patients with atrial fibrillation J Am Coll Cardiol 64 2014 1658 1665
23. D.E. Singer, and M.D. Ezekowitz Adding rigor to stroke risk prediction in atrial fibrillation J Am Coll Cardiol 65 2015 233 235
24. R. Pisters, D.A. Lane, F. Marin, and et al. Stroke and thromboembolism in atrial fibrillation Circ J 76 2012 2289 2304
25. Stroke Risk in Atrial Fibrillation Working Group Independent predictors of stroke in patients with atrial fibrillation: a systematic review Neurology 69 2007 546 554
26. A.S. Go, M.C. Fang, N. Udaltsova, and et al. Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study Circulation 119 2009 1363 1369
27. J.B. Olesen, G.Y. Lip, A. Kamper, and et al. Stroke and bleeding in atrial fibrillation with chronic kidney disease N Engl J Med 367 2012 625 635
28. V. Roldán, F. Marin, S. Manzano-Fernandez, and et al. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation? Thromb Haemost 109 2013 956 960
29. E. Herrett, S.L. Thomas, W.M. Schoonen, and et al. Validation and validity of diagnoses in the General Practice Research Database: a systematic review Br J Clin Pharmacol 69 2010 4 14
30. N.F. Khan, S.E. Harrison, and P.W. Rose Validity of diagnostic coding within the General Practice Research Database: a systematic review Br J Gen Pract 60 2010 e1288-36